Susquehanna Fundamental Investments’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Sell |
116,362
-53,984
| -32% | -$961K | 0.06% | 330 |
|
|
2025
Q1 | $3.04M | Buy |
+170,346
| New | +$3.04M | 0.04% | 425 |
|
|
2023
Q2 | – | Sell |
-5,865
| Closed | -$353K | – | 805 |
|
|
2023
Q1 | $353K | Sell |
5,865
-46,401
| -89% | -$2.79M | 0.01% | 756 |
|
|
2022
Q4 | $3.83M | Buy |
52,266
+7,561
| +17% | +$555K | 0.07% | 350 |
|
|
2022
Q3 | $3.4M | Buy |
+44,705
| New | +$3.4M | 0.06% | 430 |
|
|
2022
Q1 | $6.72M | Buy |
81,151
+40,869
| +101% | +$3.39M | 0.13% | 222 |
|
|
2021
Q4 | $3.02M | Buy |
40,282
+6,624
| +20% | +$497K | 0.08% | 311 |
|
|
2021
Q3 | $3.91M | Buy |
33,658
+21,513
| +177% | +$2.5M | 0.07% | 370 |
|
|
2021
Q2 | $2.69M | Buy |
+12,145
| New | +$2.69M | 0.05% | 499 |
|